Location History:
- Zurich, CH (2016 - 2019)
- Zürich, CH (2019)
Company Filing History:
Years Active: 2016-2019
Certainly! Here is the article about inventor Matthias Valentin Westphal:
Title: Unveiling the Innovations of Matthias Valentin Westphal
Introduction:
Matthias Valentin Westphal is a prolific inventor based in Zurich, Switzerland. With an impressive total of 5 patents to his name, Westphal has been making significant contributions to the field of medicinal compounds and pharmacology.
Latest Patents:
1. [1,2,3]triazolo[4,5-d]pyrimidine derivatives: Westphal's recent innovation involves a groundbreaking compound of formula (I) that demonstrates potential for medicinal use, with R to R' as crucial defining factors.
2. [1,2,3]triazolo[4,5-D]pyrimidine derivatives with affinity for the type-2 cannabinoid receptor: Another notable patent by Westphal includes a compound of formula (I) exhibiting affinity for the type-2 cannabinoid receptor, opening new avenues in pharmacological research.
Career Highlights:
Currently employed at Hoffmann-La Roche Inc., a renowned pharmaceutical company, Westphal continues to drive innovation and excellence in the industry. His dedication to advancing medical science is truly commendable.
Collaborations:
Westphal's professional journey is marked by collaborations with esteemed colleagues such as Uwe Grether and Luca Claudio Gobbi. Together, they have contributed to the development of cutting-edge pharmaceutical solutions.
Conclusion:
In conclusion, Matthias Valentin Westphal's impressive portfolio of patents underscores his status as a visionary inventor in the realm of medicinal compounds. His work not only showcases his scientific prowess but also highlights his unwavering commitment to improving healthcare and advancing pharmaceutical research.